Videos de Experimentos Relacionados
Pruebas de análisis de catecolaminas plasmáticas.
Lancet (London, England)
|May 10, 1980
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Neuropsychology consultation to identify learning disorders in children and adolescents: a proposal based on lessons learned during the COVID-19 pandemic.
Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence·2022
Same author
What is a processing speed weakness? Importance of cognitive ability when defining processing speed in a child psychiatric population.
Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence·2021
Same author
Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study.
Translational psychiatry·2016
Same author
Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system.
Molecular psychiatry·2014
Same author
Localization of Insulin-Like Growth Factor-II Receptors in Rat Brain by in vitro Autoradiography and Immunohistochemistry.
Journal of neuroendocrinology·2011
Same author
Autoradiographic localization and quantification of components of the Renin-Angiotensin system in tissues.
Methods in molecular medicine·2011
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026